Measles, Rubella and Congenital Rubella Syndrome (CRS) Country Profile

Chile

Introduction

The measles and rubella country profile aims to facilitate the analysis of data compiled in the last five years. This profile was only developed for those countries who officially reported vaccination coverage and case by case surveillance and laboratory data to the Pan American Health Organization (PAHO). There may be minor differences in the country profile if the country has updated data that was not reported to PAHO. The country profile will be automatically updated twice per year: at the end of April (surveillance data) and at the end of September (vaccination coverage data).

Note

The latest update dates for this country profile are available in the Update dates section.

General Information

Demographic data, 2023.

Last endemic cases by year and disease.

Vaccination schedule.

Accumulation of susceptibles for measles and rubella.

Epidemiology and Quality of Surveillance

Plot

Distribution of suspected MR cases and notification rate at the national level, 2019-2023.

Minimum notification rate: 2 cases per 100,000 population.

Table

Distribution of suspected MR cases and notification rate at the national level, 2019-2023.

Plot

Distribution of suspected CRS cases and notification rate at the national level, 2019-2023.

Minimum notification rate: 1 case per 10,000 live births.

Table

Distribution of suspected CRS cases and notification rate at the national level, 2019-2023.

Weekly

Reported cases of measles and rubella by epidemiological week and final classification: confirmed, discarded and under investigation, 2019-2023.

Yearly

Reported cases of measles and rubella by year and final classification: confirmed, discarded and under investigation, 2019-2023.

Table

Reported cases of measles and rubella by epidemiological year and final classification, 2019-2023.

Distribution of reported measles and rubella cases and incidence rate by age group, 2019-2023.

Performance indicators of measles and rubella surveillance by year, 2019-2023.

Proportion of the 11 variables reported for adequate investigation indicator, 2023.

(Investigation in ≤48 hours: 63%, Suspected MR cases: 203)

Municipalities reporting measles and rubella suspected cases by year, 2019-2023.

Laboratory Surveillance

Table

Criteria used to discard suspected measles and rubella cases by year, 2019-2023.

Plot

Distribution of discarded measles and rubella suspected cases by basis for discarding, 2019-2023.

Analysis of Vaccination Coverage and Population Cohorts

Plots

Coverage of the first dose of measles-mumps-rubella (MMR1) vaccine, number of doses administered, and number of children 1 year of age, 2019-2023.

Coverage of the second dose of measles-mumps-rubella (MMR2) vaccine, number of doses administered, and number of children 36 month(s) of age, 2019-2023.

Table

Vaccination coverage with first and second dose of measles-mumps-rubella (MMR1 and MMR2) vaccines by target population and administered doses, 2019-2023.

Plots

Proportion of municipalities by MMR1 vaccination coverage ranges, 2019-2023.

Proportion of children living in those municipalities for MMR1 vaccination coverage ranges, 2019-2023.

Proportion of municipalities by MMR2 vaccination coverage ranges, 2019-2023.

Proportion of children living in those municipalities for MMR2 vaccination coverage ranges, 2019-2023.

Table

Proportion of municipalities with MMR1 and MMR2 coverage ranges and proportion of children living in those municipalities, 2019-2023.

References

Update dates

The latest update dates for this country profile are shown below. Note that the Year of data reflects the year up to which the data are available, while the Latest update date reflects the date on which any amends, modifications and/or withdrawals of data from member countries or territories was performed.